Mammography

Learn more about what Canon Medical will be showcasing virtually at RSNA 2021.

The work of a breast imager goes far beyond the pink-out of every October.

A recent article in Clinical Imaging suggests a three-pronged education approach to address healthcare disparities in radiology.

Artificial intelligence can help seek out and identify high-risk patients who might benefit from more extensive screening.

The impact of digital breast tomosynthesis on screening performance and screen-detected cancers appears to generalize beyond trials and academic centers to the community setting.

Feminizing hormone therapy may increase the risk of breast cancer in transgender women, a growing body of research suggests, underscoring a need for health care providers to understand the risks, breast imaging features, and health care needs of this demographic.

A nuanced approach is needed to weigh the risk of vaccination-associated axillary lymphadenopathy against the risk of delaying breast cancer screening.

Age, race, and insurance all factor in to whether women got their annual exams.

Software improves on breast density assessment algorithm with artificial intelligence.

Here's what to expect this week on Diagnostic Imaging.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Race is the most significant contributor to delays with breast cancer diagnosis.

Including a DNA-methylation analysis could improve early diagnosis for BI-RADS 4 patients.

One-click tool is designed to deliver precision consistently across all imaging modalities.

Combination also leads to a reduction in the false-negative rate.

The latest products released on the market for Quarter 2 2021.

Digital breast tomosynthesis offers benefits over mammography, but it is enough to change screening?

Several factors – other than length of clinical experience – weigh into a provider’s interpretive accuracy.

Here's what to expect this week on Diagnostic Imaging.

Primary care providers are less likely to recommend breast MRI for screening high-risk women.

Breast MRI is a good tool for supplemental screening in women who have a personal history of breast cancer.

Cancer screening rates drop more significantly among women in racial and ethnic minority groups, as well as those living in rural locations.

Here's what to expect this week on Diagnostic Imaging.

Meg Eckenroad, Hologic’s vice president of women’s health, discusses the motivation and goals of the new $20-million Project Health Equality.

Dana Bonaminio, M.D., Women’s Imaging National Subspecialty Lead from Radiology Partners, offers tips and guidance on what providers should make sure women know about their breast health.